The standing of Humana among financial experts is revealed through an in-depth exploration of recent analyst actions. The ...

UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs ...

Health insurance company Humana (NYSE:HUM) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.4% year on ...

Is Humana a buy or sell going into earnings? Read our full analysis ... shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5.2% on ...

Humana has a P/E ratio of 16.4 based on its 12 month trailing earnings per share of $14.17. Considering its future earnings ...

CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my ...

Shares of UnitedHealth Group ended down 22% Thursday after the health-care giant's first-quarter results fell short of ...

US stock futures slipped lower as Wall Street braced for a busy day of Big Tech earnings and digested President Trump's latest move on tariffs.

US stocks dropped as Wall Street braced for a busy day of Big Tech earnings and digested President Trump's latest move on tariffs.